New approaches to the treatment of rosacea on the basis pathogenesis factors and clinical forms
Open Access
- 22 June 2023
- journal article
- review article
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 26 (3) , 251-262
Abstract
Uncovering the molecular mechanisms of the rosacea pathogenesis and treatment are still of great importance. The review encompasses the modern knowledge of rosacea classification, characterization of the severity of the course of the subtypes, and pathogenesis features. Recent methods of rosacea treatment are presented, including the use of botulinum neuroprotein for the correction of the erythematous-telangiectatic subtype of the dermatosis. The relevance of this problem is due to the chronic course of the disease and the peculiarity of the localization of rosacea manifestations that leads to a traumatic effect and often causes social exclusion of patients. The rise of the rosacea incidences, along with other reasons like characteristics of the course of dermatosis, accompanied by frequent long-term relapses, is due to the resistance to generally accepted methods of drug therapy, often resulting in shortened clinical remission. All the factors lead to decreasing of patients life quality that require the search for effective therapy approaches. Among modern rosacea therapy, the application of botulinum neuroprotein is widely used; however, the clinical studies confirming the effectiveness of this technique are not presented enough.Keywords
This publication has 42 references indexed in Scilit:
- Prevalence of rosacea in the general population of Germany and Russia – The RISE studyJournal of the European Academy of Dermatology and Venereology, 2016
- Rosacea: modern aspects of the etiology and pathogenesisRussian Journal of Clinical Dermatology and Venereology, 2015
- Impact of Intradermal AbobotulinumtoxinA on Facial Erythema of RosaceaDermatologic Surgery, 2015
- Botulinum Toxin for the Treatment of Menopausal Hot FlushesDermatologic Surgery, 2011
- Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skinPain, 2010
- Risk factors associated with rosaceaJournal of the European Academy of Dermatology and Venereology, 2010
- Sensing the Deadliest Toxin: Technologies for Botulinum Neurotoxin DetectionToxins, 2010
- Increased serine protease activity and cathelicidin promotes skin inflammation in rosaceaNature Medicine, 2007
- GSTM1 and GSTT1 null genotypes as possible heritable factors of rosaceaPhotodermatology, Photoimmunology & Photomedicine, 2006
- Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of RosaceaJournal of the American Academy of Dermatology, 2002